Trajectories of eGFR decline over a four year period: the eGFR Follow-up Study (#32)

11:30 AM

Federica Barzi

ADS Clinical Orals - Renal & Foot Complications

Soluble urokinase plasminogen activator receptor (suPAR) levels and decline in estimated glomerular filtration rate (eGFR) in patients with diabetes (#31)

11:15 AM

Richard MacIsaac

ADS Clinical Orals - Renal & Foot Complications

The contribution of glycaemic status to the progression of kidney disease among Indigenous Australians with and without albuminuria– the eGFR follow-up study (#30)

11:00 AM

Elizabeth LM Barr

ADS Clinical Orals - Renal & Foot Complications

Tumour Necrosis Factor-alpha Receptor 1 and 2 are Reduced in patients with Type 1 Diabetes and Hyperfiltration (#34)

12:00 PM

Jas-mine Seah

ADS Clinical Orals - Renal & Foot Complications

Functional Magnetic Resonance Imaging (MRI) changes in Type 1 Diabetes with and without Renal Hyperfiltration (#221)

2:00 PM

Jas-mine Seah

ADS Clinical Poster Award Session

The Effect Of Salt Versus Placebo Supplementation On Haematocrit Levels In Type Two Diabetes Mellitus (#321)

2:00 PM

Adrian Michalopoulos

ADS Clinical Poster Session - Diabetes Complications (general)